Investing.com - Financial Markets Worldwide

Corline Biomedical AB (CLBIO)

Stockholm
Currency in SEK
18.10
-0.35(-1.90%)
Real-time Data·
Earnings results expected in 7 days
CLBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
17.5518.45
52 wk Range
5.9827.20
Key Statistics
Edit
Prev. Close
18.45
Open
18.05
Day's Range
17.55-18.45
52 wk Range
5.98-27.2
Volume
16.42K
Average Volume (3m)
57.02K
1-Year Change
179.55%
Book Value / Share
3.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 10
High return over the last year
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Corline Biomedical AB Company Profile

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound. The company’s products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; and CHC, which is used for the treatment of soft tissue injuries. The company was incorporated in 1991 and is based in Uppsala, Sweden.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
13
Market
Sweden

Compare CLBIO to Peers and Sector

Metrics to compare
CLBIO
Peers
Sector
Relationship
P/E Ratio
−19.2x0.0x−0.6x
PEG Ratio
0.080.000.00
Price/Book
5.6x0.0x2.6x
Price / LTM Sales
45.1x0.0x3.3x
Upside (Analyst Target)
78.9%0.0%41.3%
Fair Value Upside
Unlock0.0%4.9%Unlock

Earnings

Latest Release
Aug 26, 2025
EPS / Forecast
-0.13 / --
Revenue / Forecast
2.20M / 3.80M
EPS Revisions
a
a
Unlock
Last 90 days

CLBIO Income Statement

FAQ

What Stock Exchange Does Corline Biomedical AB Trade On?

Corline Biomedical AB is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Corline Biomedical AB?

The stock symbol for Corline Biomedical AB is "CLBIO."

What Is the Corline Biomedical AB (CLBIO) Afterhours Price Today? (Afterhours variable test: 0.00) Current Date: 14 Nov 2025

After hours price: 0.00. After hours price change (units): 0.00. Price change percentage: 0.00%

What Is the Corline Biomedical AB Market Cap?

As of today, Corline Biomedical AB market cap is 443.28M.

What Is Corline Biomedical AB's Earnings Per Share (TTM)?

The Corline Biomedical AB EPS (TTM) is -1.01.

When Is the Next Corline Biomedical AB Earnings Date?

Corline Biomedical AB will release its next earnings report on 20 Nov 2025.

From a Technical Analysis Perspective, Is CLBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Corline Biomedical AB Stock Split?

Corline Biomedical AB has split 2 times.

How Many Employees Does Corline Biomedical AB Have?

Corline Biomedical AB has 13 employees.

What is the current trading status of Corline Biomedical AB (CLBIO)?

As of 14 Nov 2025, Corline Biomedical AB (CLBIO) is trading at a price of 18.10, with a previous close of 18.45. The stock has fluctuated within a day range of 17.55 to 18.45, while its 52-week range spans from 5.98 to 27.20.

What Is Corline Biomedical AB (CLBIO) Price Target According to Analysts?

The average 12-month price target for Corline Biomedical AB is SEK33, with a high estimate of SEK33 and a low estimate of SEK33. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +82.32% Upside potential.

What Is the CLBIO After Hours Price?

CLBIO's last after hours stock price is 0.00, the stock has decreased by 0.00, or 0.00%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.